Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients represent a powerful tool for biomedical research and may provide a source for replacement therapies. However, the use of viruses encoding the reprogramming factors represents a major limitation of the current technology s...
Main Authors: | Soldner, Frank, Hockemeyer, Dirk, Beard, Caroline, Gao, Qing, Bell, George W., Cook, Elizabeth G., Hargus, Gunnar, Blak, Alexandra, Cooper, Oliver, Mitalipova, Maisam, Isacson, Ole, Jaenisch, Rudolf |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier B.V.
2015
|
Online Access: | http://hdl.handle.net/1721.1/96268 https://orcid.org/0000-0001-9724-6776 |
Similar Items
-
Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats
by: Jaenisch, Rudolf, et al.
Published: (2014) -
Induced Pluripotent Stem Cells Meet Genome Editing
by: Hockemeyer, Dirk, et al.
Published: (2018) -
Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell‐derived microglia‐like cells
by: Murai, Nobuhito, et al.
Published: (2021) -
Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues
by: Hanna, Jacob, et al.
Published: (2015) -
Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells
by: Guenther, Matthew G., et al.
Published: (2015)